Carl M. Gay

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-4907-0718

发表论文 359 篇 · 总被引 8869 次 · h-index 40

代表论文

• A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS (2025 · Lung Cancer · 被引 2)
• Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer (2025 · Molecular Cancer · 被引 2)
• Real-world patient characteristics, treatment patterns and clinical outcomes in patients diagnosed with extra-pulmonary neuroendocrine carcinoma (epNEC): A non-interventional multimodal database analysis in the US. (2026 · Journal of Clinical Oncology · 被引 1)
• Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer (2026 · British Journal of Cancer · 被引 1)
• The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC–High SCLC (2025 · Journal of Thoracic Oncology · 被引 1)
• CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)